Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties
Main Authors: | Daniel Scholes Rosenbloom, Ping Zhao, Vikram Sinha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12550 |
Similar Items
-
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01) -
SARS‐CoV‐2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy
by: Shengyuan Zhang, et al.
Published: (2023-10-01) -
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
by: Xiaonan Liu, et al.
Published: (2021-11-01) -
Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
by: Paolo Calligari, et al.
Published: (2020-04-01) -
Antiviral Effect of Budesonide against SARS-CoV-2
by: Natalie Heinen, et al.
Published: (2021-07-01)